Literature DB >> 14645250

Domain-specific modification of heparan sulfate by Qsulf1 modulates the binding of the bone morphogenetic protein antagonist Noggin.

Beth L Viviano1, Stephenie Paine-Saunders, Nijole Gasiunas, John Gallagher, Scott Saunders.   

Abstract

We have reported previously that Noggin is a heparin-binding protein and associates with the cell surface through heparan sulfate proteoglycans, where it remains functional for the binding of bone morphogenetic proteins (BMPs). Here we report that the binding of Noggin to the cell surface is highly selective for heparan sulfate and that specific structural features are required for the interaction. Noggin binds most efficiently to heparin sequences composed of 10 or more monosaccharides; N-, 6-O-, and 2-O-sulfates contribute to this interaction. In addition, we have shown that the developmentally regulated endosulfatase Qsulf1 selectively removes sulfate groups from the 6-O position of sugars within the most highly sulfated S domains of heparan sulfate, whereas 6-O-sulfates in the NA/NS domains are not substrates for the enzyme. The activity of Qsulf1 in cells in culture results in the release of Noggin from the cell surface and a restoration of BMP responsiveness to the cells. This shows that Noggin binds to the S domains of heparan sulfate and provides evidence that, in addition to modulating Wnt signaling in vivo by the release of heparan sulfate bound Wnt, Qsulf1 also modulates BMP signaling by the release of surface-bound Noggin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14645250     DOI: 10.1074/jbc.M310691200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  87 in total

1.  Gene trap disruption of the mouse heparan sulfate 6-O-endosulfatase gene, Sulf2.

Authors:  David H Lum; Jenille Tan; Steven D Rosen; Zena Werb
Journal:  Mol Cell Biol       Date:  2006-11-20       Impact factor: 4.272

Review 2.  Sulfated glycosaminoglycans in protein aggregation diseases.

Authors:  Kazuchika Nishitsuji; Kenji Uchimura
Journal:  Glycoconj J       Date:  2017-04-11       Impact factor: 2.916

3.  Extracellular sulfatases support cartilage homeostasis by regulating BMP and FGF signaling pathways.

Authors:  Shuhei Otsuki; Sarah R Hanson; Shigeru Miyaki; Shawn P Grogan; Mitsuo Kinoshita; Hiroshi Asahara; Chi-Huey Wong; Martin K Lotz
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-17       Impact factor: 11.205

4.  Functional consequences of the subdomain organization of the sulfs.

Authors:  Renhong Tang; Steven D Rosen
Journal:  J Biol Chem       Date:  2009-06-11       Impact factor: 5.157

Review 5.  Extracellular matrix and its receptors in Drosophila neural development.

Authors:  Kendal Broadie; Stefan Baumgartner; Andreas Prokop
Journal:  Dev Neurobiol       Date:  2011-11       Impact factor: 3.964

Review 6.  Heparan sulfate proteoglycans and their binding proteins in embryo implantation and placentation.

Authors:  Catherine B Kirn-Safran; Sonia S D'Souza; Daniel D Carson
Journal:  Semin Cell Dev Biol       Date:  2007-07-31       Impact factor: 7.727

7.  Modification degrees at specific sites on heparan sulphate: an approach to measure chemical modifications on biological molecules with stable isotope labelling.

Authors:  Zhengliang L Wu; Miroslaw Lech
Journal:  Biochem J       Date:  2005-07-15       Impact factor: 3.857

Review 8.  Syndecans in cartilage breakdown and synovial inflammation.

Authors:  Thomas Pap; Jessica Bertrand
Journal:  Nat Rev Rheumatol       Date:  2012-10-23       Impact factor: 20.543

Review 9.  Regulation of intracellular signaling by extracellular glycan remodeling.

Authors:  Randy B Parker; Jennifer J Kohler
Journal:  ACS Chem Biol       Date:  2010-01-15       Impact factor: 5.100

10.  Sulf-2, a heparan sulfate endosulfatase, promotes human lung carcinogenesis.

Authors:  H Lemjabbar-Alaoui; A van Zante; M S Singer; Q Xue; Y-Q Wang; D Tsay; B He; D M Jablons; S D Rosen
Journal:  Oncogene       Date:  2009-10-26       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.